MedTrace Logo

Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies

NCT00432588 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2007-06-01

No results posted yet for this study

Summary

Hypothesis (H0): Labor duration and obstetric complications are not significantly different in the three groups (misoprostol-dinoprostone-oxytocin).

Conditions

  • Preeclampsia
  • Fetal Death
  • Fetal Membranes, Premature Rupture

Interventions

DRUG

misoprostol

DRUG

dinoprostone

Sponsors & Collaborators

  • Hormozgan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mitra Ahmad Soltani · Hormozgan University of Medical Sciences

  • Minoo Rajaee Lari, Perinatologist - Obs and Gyn · Department of Obs and Gyn - HUMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00432588 on ClinicalTrials.gov